Suppr超能文献

环苯扎林可提高婴儿利什曼原虫中的活性氧水平并降低感染小鼠体内的寄生虫负荷。

Cyclobenzaprine Raises ROS Levels in Leishmania infantum and Reduces Parasite Burden in Infected Mice.

作者信息

Cunha-Júnior Edézio Ferreira, Andrade-Neto Valter Viana, Lima Marta Lopes, da Costa-Silva Thais Alves, Galisteo Junior Andres J, Abengózar Maria A, Barbas Coral, Rivas Luis, Almeida-Amaral Elmo Eduardo, Tempone Andre Gustavo, Torres-Santos Eduardo Caio

机构信息

Laboratório de Bioquímica de Tripanosomatídeos, Instituto Oswaldo Cruz, Fiocruz, Rio de Janeiro, Brasil.

Instituto de Medicina Tropical, Universidade de São Paulo, São Paulo, São Paulo, Brazil.

出版信息

PLoS Negl Trop Dis. 2017 Jan 3;11(1):e0005281. doi: 10.1371/journal.pntd.0005281. eCollection 2017 Jan.

Abstract

BACKGROUND

The leishmanicidal action of tricyclic antidepressants has been studied and evidences have pointed that their action is linked to inhibition of trypanothione reductase, a key enzyme in the redox metabolism of pathogenic trypanosomes. Cyclobenzaprine (CBP) is a tricyclic structurally related to the antidepressant amitriptyline, differing only by the presence of a double bond in the central ring. This paper describes the effect of CBP in experimental visceral leishmaniasis, its inhibitory effect in trypanothione reductase and the potential immunomodulatory activity.

METHODOLOGY/PRINCIPAL FINDINGS: In vitro antileishmanial activity was determined in promastigotes and in L. infantum-infected macrophages. For in vivo studies, L. infantum-infected BALB/c mice were treated with CBP by oral gavage for five days and the parasite load was estimated. Trypanothione reductase activity was assessed in the soluble fraction of promastigotes of L. infantum. For evaluation of cytokines, L. infantum-infected macrophages were co-cultured with BALB/c splenocytes and treated with CBP for 48 h. The supernatant was analyzed for IL-6, IL-10, MCP-1, IFN-γ and TNF-α. CBP demonstrated an IC50 of 14.5±1.1μM and an IC90 of 74.5±1.2 μM in promastigotes and an IC50 of 12.6±1.05 μM and an IC90 of 28.7±1.3 μM in intracellular amastigotes. CBP also reduced the parasite load in L. infantum-infected mice by 40.4±10.3% and 66.7±10.5% in spleen at 24.64 and 49.28 mg/kg, respectively and by 85.6±5.0 and 89.3±4.8% in liver at 24.64 and 49.28mg/kg, after a short-term treatment. CBP inhibited the trypanothione reductase activity with a Ki of 86 ± 7.7 μM and increased the ROS production in promastigotes. CBP inhibited in 53% the production of IL-6 in infected macrophages co-culture.

CONCLUSION/SIGNIFICANCE: To the best of our knowledge, this study is the first report of the in vivo antileishmanial activity of the FDA-approved drug CBP. Modulation of immune response and induction of oxidative stress in parasite seem to contribute to this efficacy.

摘要

背景

三环类抗抑郁药的杀利什曼原虫作用已得到研究,有证据表明其作用与抑制锥虫硫醇还原酶有关,锥虫硫醇还原酶是致病性锥虫氧化还原代谢中的关键酶。环苯扎林(CBP)是一种结构上与抗抑郁药阿米替林相关的三环类药物,仅在中心环上存在一个双键有所不同。本文描述了CBP在实验性内脏利什曼病中的作用、其对锥虫硫醇还原酶的抑制作用以及潜在的免疫调节活性。

方法/主要发现:在无鞭毛体和感染婴儿利什曼原虫的巨噬细胞中测定体外抗利什曼原虫活性。对于体内研究,通过口服灌胃用CBP处理感染婴儿利什曼原虫的BALB/c小鼠5天,并估计寄生虫负荷。在婴儿利什曼原虫无鞭毛体的可溶性部分中评估锥虫硫醇还原酶活性。为了评估细胞因子,将感染婴儿利什曼原虫的巨噬细胞与BALB/c脾细胞共培养,并用CBP处理48小时。分析上清液中的IL-6、IL-10、MCP-1、IFN-γ和TNF-α。CBP在无鞭毛体中的IC50为14.5±1.1μM,IC90为74.5±1.2μM,在细胞内无鞭毛体中的IC50为12.6±1.05μM,IC90为28.7±1.3μM。短期治疗后分别以24.64和49.28mg/kg的剂量,CBP还使感染婴儿利什曼原虫小鼠脾脏中的寄生虫负荷分别降低了40.4±10.3%和66.7±10.5%,在肝脏中分别降低了85.6±5.0%和89.3±4.8%。CBP以86±7.7μM的Ki抑制锥虫硫醇还原酶活性,并增加无鞭毛体中的活性氧产生。CBP在感染巨噬细胞共培养物中抑制了53%的IL-6产生。

结论/意义:据我们所知,本研究是关于FDA批准药物CBP体内抗利什曼原虫活性的首次报道。对免疫反应的调节和寄生虫中氧化应激的诱导似乎促成了这种疗效。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b5f/5234845/e51bed2c40ca/pntd.0005281.g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验